Related Experiment Video
Updated: May 2, 2026

A Protocol for Analyzing Hepatitis C Virus Replication
Published on: June 26, 2014
Acute hepatitis C: clinical and laboratory diagnosis, course of the disease, treatment
E Sagnelli1, T Santantonio, N Coppola
1Department of Mental Health and Public Medicine, Section of Infectious Diseases, Second University of Naples, via L. Armanni, No. 3, 80135, Naples, Italy, evangelista.sagnelli@unina2.it.
Insights
Early diagnosis of acute hepatitis C (AHC) is crucial for preventing chronic infection. Short-term interferon treatment can halt AHC progression in most cases, highlighting the importance of timely intervention.
Area of Science:
- Hepatology
- Virology
- Infectious Diseases
Background:
- Acute hepatitis C (AHC) is often asymptomatic, leading to delayed diagnosis and a high rate of progression to chronic infection.
- Understanding risk factors and natural history is key to managing AHC effectively.
Purpose of the Study:
- To review current literature on hepatitis C virus (HCV) transmission, diagnosis, natural history, and antiviral treatment of AHC.
- To emphasize the clinical significance of early AHC diagnosis and treatment.
Main Methods:
- Literature review of studies on AHC risk factors, diagnosis, natural history, and treatment.
- Evaluation of diagnostic methods, including anti-HCV seroconversion and newer laboratory techniques.
Main Results:
- Anti-HCV seroconversion is the gold standard for AHC diagnosis but is often uninformative due to unknown prior status.
- Early, short-term interferon treatment effectively prevents chronicity in the majority of AHC patients.
- Newer laboratory methods may help differentiate AHC from acute exacerbations of chronic HCV infection.
Conclusions:
- Early diagnosis of AHC is clinically relevant, enabling prompt interferon treatment to prevent chronicity.
- Developing and utilizing advanced laboratory diagnostics is recommended for accurate AHC identification.
Introduction:
Acute hepatitis C (AHC) is asymptomatic in about 70-80 % of cases and, therefore, is usually undiagnosed. Although the clinical course is typically mild, AHC has a high rate of transition to chronicity.
Material And Methods:
We evaluated the literature data concerning risk factors for HCV transmission, diagnosis, natural history, and antiviral treatment of AHC.
Results:
Although new methods have been developed, anti-HCV seroconversion remains the gold standard for the diagnosis of AHC. This phenomenon, however, is identifiable in less than half of cases in the everyday clinical practice, since most AHC patients do not know their previous anti-HCV/HCV-RNA status. An early short-term interferon treatment in AHC patients prevents progression to chronicity in most of treated patients.
Conclusion:
The literature data give evidence of the clinical relevance of an early diagnosis of AHC for an early short-term interferon treatment. There is also the suggestion to use newly developed laboratory methods to distinguish AHC from an acute exacerbation of a chronic HCV infection.
Related Concept Videos
Hepatitis
Viral Hepatitis I: Introduction
Cytomegalovirus Disease
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Cirrhosis I: Introduction
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

